Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study to Investigate the Skin Sensitization Potential of MFC51123

NCT02192203 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02192203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02192203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study to Investigate the Skin Sensitization Potential of MFC51123
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Completed
Start date
April 1, 2014
Completion date
July 15, 2014
Enrollment
227 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain